ACTRN12618000103268
撤回
未知
Early Feasibility Study of the CardiAQ-Edwards ™ Transcatheter Mitral Valve (TMV) System for patients with clinically significant, symptomatic mitral regurgitation requiring either mitral valve repair or replacement who are at high surgical risk as assessed by the Heart Team.
Edwards Lifesciences, LLT0 个研究点目标入组 15 人2018年1月23日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Mitral Regurgitation
- 发起方
- Edwards Lifesciences, LLT
- 入组人数
- 15
- 状态
- 撤回
- 最后更新
- 6年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Clinically significant, symptomatic mitral regurgitation
- •High risk for open\-heart surgery
- •Meets anatomical criteria
排除标准
- •Unsuitable anatomy
- •Patient is inoperable
结局指标
主要结局
未指定
相似试验
撤回
不适用
Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS)Mitral InsufficiencyHeart Valve DiseaseCardiovascular DiseaseHeart DiseaseNCT02515539Edwards Lifesciences
已完成
不适用
Development and evaluation of an advanced cardiovascular life support simulation-based training program for nursing studentoneJPRN-UMIN000048710Hokkaido University8
招募中
不适用
FAST study: Feasibility ASessment of circulating Tumour DNA (ctDNA) in the diagnosis of advanced lung cancer in patientsung cancerLung cancerCancer - Lung - Non small cellACTRN12624000462583niversity of Otago50
终止
不适用
A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)Mitral InsufficiencyHeart Valve DiseaseCardiovascular DiseaseHeart DiseaseNCT02478008Edwards Lifesciences2
已完成
2 期
Feasibility trial of a staged epicardial and endocardial approach for treatment of patients with persistent or long standing persistent atrial fibrillation with radiofrequency ablatioatrial fibrillationfibrillation10007521NL-OMON37310Atricure Inc.6